Adverum Biotechnologies, Inc. (ADVM) Earnings History
Annual and quarterly earnings data from 2012 to 2024
Loading earnings history...
ADVM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ADVM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -13915.9% | -13092.7% |
| 2023 | 100.0% | -3581.7% | -3392.1% |
| 2022 | - | - | - |
| 2021 | 100.0% | -1948.3% | -1940.5% |
| 2020 | - | - | - |
Download Data
Export ADVM earnings history in CSV or JSON format
Free sign-in required to download data
Adverum Biotechnologies, Inc. (ADVM) Earnings Overview
As of May 8, 2026, Adverum Biotechnologies, Inc. (ADVM) reported trailing twelve-month net income of -$204M, reflecting -227.7% year-over-year growth. The company earned $-8.70 per diluted share over the past four quarters, with a net profit margin of -13092.7%.
Looking at the long-term picture, ADVM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2012.
Adverum Biotechnologies, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including OCGN (-$68M net income, -1537.4% margin), EDIT (-$160M net income), KRYS ($225M net income, 52.6% margin), ADVM has room to improve margins relative to the peer group. Compare ADVM vs OCGN →
ADVM Earnings vs Peers
Earnings metrics vs comparable public companies
ADVM Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$131M | -7.2% | -$139M | $-6.62 | -13092.7% | -13915.9% |
| 2023 | -$122M | +21.0% | -$129M | $-2.02 | -3392.1% | -3581.7% |
| 2022 | -$155M | -6.2% | -$157M | $-2.67 | - | - |
| 2021 | -$146M | -23.9% | -$146M | $-1.48 | -1940.5% | -1948.3% |
| 2020 | -$118M | -82.2% | -$118M | $-1.26 | - | - |
| 2019 | -$64M | +11.2% | -$69M | $-0.87 | -25794.4% | -27418.0% |
| 2018 | -$73M | -29.4% | -$78M | $-1.18 | -4505.4% | -4843.7% |
| 2017 | -$56M | +50.6% | -$59M | $-1.29 | -3036.6% | -3182.6% |
| 2016 | -$114M | -139.7% | -$115M | $-3.14 | -7817.7% | -7923.3% |
| 2015 | -$47M | -86.8% | -$48M | $-1.84 | -2046.3% | -2062.2% |
See ADVM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADVM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADVM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADVM — Frequently Asked Questions
Quick answers to the most common questions about buying ADVM stock.
Is ADVM growing earnings?
ADVM EPS fell to $-8.70, with earnings declining -227.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-204M.
What are ADVM's profit margins?
Adverum Biotechnologies, Inc. net margin is -13092.7%, with operating margin at -13915.9%. Below-average margins reflect competitive or cost pressures.
How consistent are ADVM's earnings?
ADVM earnings data spans 2012-2024. The declining earnings trend is -227.7% YoY. Historical data enables comparison across business cycles.